Arjuna is an unusually cooperative ingredient to formulate with. It is stable, it tablets well, it has a water-soluble grade for beverages, and it carries a classical dosing tradition that gives formulators a sensible starting point. Where arjuna gets difficult is not the formulation. It is the label.
Where Arjuna Is Used
Commercially, arjuna bark extract appears across a fairly consistent set of applications:
- Cardiovascular and circulatory supplements — the dominant category, usually capsules or tablets;
- Classical Ayurvedic preparations — arjuna ksheerpaka (a milk decoction), kwath decoctions, and churna blends;
- Sports and endurance formulations — cardiorespiratory and stamina positioning;
- Senior nutrition — daily-tonic and multi-botanical wellness formats;
- Functional beverages — shots, herbal teas, effervescents, using the water-soluble grade.
Formulation Characteristics
Solubility
The standard tannin-standardised grade is partially water-soluble — adequate for capsules, tablets and dry blends. For clear beverages, shots and effervescents, the cold-water-soluble spray-dried grade is the right specification; attempting to force the standard grade into a clear liquid format produces sediment and haze.
Arjuna's beverage use is not an export-market invention. The ksheerpaka and kwath traditions are decoction formats, so a soluble grade is closer to classical practice than a capsule is.
Taste
Astringent, and noticeably so — this is a tannin-rich bark extract. In beverages it needs masking or a format that carries astringency naturally. The classical milk decoction is, among other things, an elegant solution to this problem.
Handling
Hygroscopic. The powder will cake if left open in humid conditions, so containers should be resealed promptly after sampling and stored dry. Otherwise it is a stable, forgiving material without the thermal or oxidative sensitivities of more delicate polyphenol extracts.
Compatibility
Tannins bind proteins and can interact with iron and some alkaloids. In multi-ingredient formulations this is worth checking rather than assuming — particularly where iron salts or protein carriers are present.
The Claim Boundary
Now the difficult part, and it deserves stating plainly rather than in the hedged language these sections often attract.
Arjuna's classical indication is cardiac. That is what buyers want it for, and it is what the traditional literature describes. It is also precisely the claim that regulated markets are least willing to permit.
In the EU, cardiovascular claims for botanical ingredients are effectively unavailable under the health-claims framework. Beyond that, a product presented for the treatment or prevention of heart conditions risks being assessed as a medicinal product — by function or by presentation — rather than as a food supplement. That reclassification is a considerably larger problem than a rejected claim.
Comparable logic applies across most regulated markets, with the detail varying by jurisdiction. The specific position for your product and market belongs in your regulatory review, not in a supplier's article.
What This Means Practically
It does not mean arjuna is unsaleable in regulated markets. It means the positioning has to do the work that a claim cannot:
- Traditional-use framing travels considerably better than physiological claims. Arjuna's documented history in the Ayurvedic classical literature is genuine, specific and old — a real asset where the framework recognises traditional use;
- Category positioning — daily wellness, senior nutrition, or Ayurvedic heritage — carries the product without making a medicinal claim;
- Practitioner and Ayurvedic channels operate under different expectations from mass retail, and are where much arjuna product sits;
- Market selection matters. India and markets with established Ayurvedic frameworks handle arjuna far more comfortably than the EU does.
Advisory Labelling
A separate point from claims, and one worth raising even though it sits with the brand owner rather than the supplier.
Because arjuna is bought and used for cardiovascular purposes, consumers taking cardiac or antihypertensive medication are a foreseeable part of the user population. Whether advisory labelling is appropriate — and in what form — is a question for your regulatory and safety review. Our view is that it is better addressed openly at formulation than discovered later.
Dosing Conventions
We supply ingredients rather than finished-product doses, and dosing is properly the formulator's decision informed by their own review. What we can say is structural: the dose convention in the market is built around tannin-standardised extract, so if you switch standardisation basis — to a native-ratio extract, or to a triterpenoid-standardised material — the dose does not carry across unchanged.
This catches people out when reformulating. A 10:1 native extract and a 40% tannin extract are not interchangeable at the same weight.
Specifying for Your Format
| Format | Grade | Note |
|---|---|---|
| Capsules / tablets | 40% or 50% tannins | Standard grade, 40 mesh |
| Clear beverages / shots | Water-soluble | Astringency needs masking |
| Effervescents | Water-soluble | Check moisture control |
| Classical churna | Milled bark powder | Not an extract — priced separately |
| Full-spectrum formulations | Native ratio 10:1 / 20:1 | Dose does not map from 40% |
All grades carry the same species confirmation and arjunolic acid marker profile. Tell us your format and we will confirm the right specification.
Source Bark-Only, Marker-Profiled Arjuna Extract from India
Terminalia arjuna stem bark extract · species confirmed, wood excluded · arjunolic acid marker profile by HPLC · tannins method-stated · CoA-backed · samples for qualified buyers